AzTrials
AzTrials

Loop IleostomyPhase 2/3PHaLIRNCT03720262

Prevention of Hernia After Loop Ileostomy Reversal

A Phase 2/3 study testing Mesh reinforcement and No reinforcement in people with Loop Ileostomy, run by Karolinska Institutet at 4 sites in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Loop Ileostomy
What is being tested?
Mesh reinforcement and No reinforcement
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
208 participants
Where
4 sitesSweden
Study dates
1 Mar 2018to 31 Dec 2029
Phase
Phase 2/3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal

Who cannot join

  • Language barrier or cognitive disability
  • Recurrent cancer

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Åsa Hallqvist Everhov, MD, PhD contact

+46702264127

asa.hallqvist-everhov@sll.se

Jonas Nygren, MD, PhD contact

Jonas.Nygren@erstadiakoni.se

Sweden4 sites, 4 recruiting
  • Södertälje Hospital

    Södertälje

    Sven Bringman

    Recruiting
  • Stockholm South General Hospital

    Stockholm, 11883

    Karolina Eklöf, MD

    Recruiting
  • Ersta Hospital

    Stockholm

    Jonas Nygren, MD, PhD

    Recruiting
  • Västmanland Hospital

    Västerås

    Abbas Chabok, MD PhD

    Recruiting

Other trials in Sweden

About this study

PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.

Read the detailed description

A temporary loop ileostomy is widely used when operating rectal cancer. The ostomy is then reversed in a separate operation. Morbidity of stoma reversal is significant, but not clearly defined. One complication in connection with stoma closure is development of hernia at the former stoma site.

A hernia is a weakening of the muscular layers and the connective tissue of the abdominal wall, which may cause pain and discomfort, as well as an inconvenient bulge. A hernia could also cause more serious complication of obstructed or strangulated bowel. According to international studies, the incidence of hernia at the ostomy site varies between 7% and 35%. Many of the studies are heterogenic and some of them include both colostomies and ileostomies. Among studies that focus on reversal of ileotomies the hernia incidence varies between 11-15%. Preliminary results from a retrospective study in Stockholm indicates a frequency of 7,9%.

The best method to avoid hernia after stoma closure is not known. Most commonly surgeons tend to close the fascia in one layer with monofilament suture. In the study mentioned above 91% of the operations were done with one-layer monofilament, mostly PDS. Use of prophylactic mesh in the abdominal wall has been proposed, but there is currently insufficient scientific evidence to recommend it as a routine.

The present study is focused on loop ileostomy closure after rectal cancer. A non-heterogenous group of ostomies will serve as a base to evaluate whether the incidence of hernia may be reduced. If this study detects a decreased frequency of hernia when using prophylactic meshes, it may lead to new recommendations for this patient group.

PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery will be randomized to retro muscular mesh Ultrapro Advanced or standard treatment without mesh. Operating time, complications, LOS, pain, infections and postoperative hernia are to be studied. The patients will be identified and asked about participation when they come for postoperative control after rectal cancer operation and are planned for the ileostomy reversal after check of the rectal anastomosis. They will be given oral and written information and signed informed consent is required from all patients.

At operation the operation-protocol should be filled in. The operation notes will be written in a blinded way and the original version will be stored on paper until after the study is finished and then added to the patient chart.

At discharge from the surgical ward the patient should be planned for a follow up at the surgical clinic at 30 days postoperatively. The doctor at the follow up visit should be another than the operating surgeon. The patients should then fill in a questionnaire and the surgeon should note the postoperative complications in the 30-days follow up form. At the 30-day follow up the surgeon checks that the one-year follow up after the cancer operation is commissioned. Normally this is a CT thorax and abdomen with contrast. For the study-patients it should be complemented with the question of hernia and the CT scan shall be a CT with straining. The normal 1-year follow up for the cancer will be the follow up for the ileostomy reversal also. That means that in most cases it will take place 6-9 months after the reversal. At this control and at the three years control (after cancer operation) the patient will be given or mailed a questionnaire (the same as the 30-day questionnaire). The follow up by doctor could be done either with a clinical visit or a telephone call according to the routines of the clinic when they follow up their cancer patients. At three years follow up after cancer operation patients will also get the same questionnaire and the CT scan follow up at three years will also be with straining.

Conditions
Loop Ileostomy
Being tested
Mesh reinforcement, No reinforcement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mesh reinforcementCombination product

    Reinforcement of the abdominal wall with Ultrapro Advanced.

  • No reinforcementOther

    Suturing the abdominal wall without mesh reinforcement

Study groups in NCT03720262
Study groupRoleWhat they receive
Mesh reinforcementExperimentalRetro muscular mesh at the stoma site.
Receives: Combination Product: Mesh reinforcement
No reinforcementPlacebo comparatorStandard closure of the abdominal wall
Receives: Other: No reinforcement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hernia

    Hernia at the site of the stomal closure

    Measured: One year

Secondary outcomes (5)
  1. Operation time

    Total operation time

    Measured: Three hours

  2. Time for closing the stoma site

    Time required to close the stoma site

    Measured: One hour

  3. Hospital stay

    Days to discharge

    Measured: Seven days

  4. Postoperative pain

    Pain assessed on a Visual analogue scale ranging from 0 to 100, without subscales. 0 corresponds to no pain and 100 the most intense pain sensation imaginable.

    Measured: Thirty days

  5. Postoperative complications

    Complications, including surgical site infections

    Measured: Thirty days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2018
  2. Study start1 Mar 2018
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
208 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03720262
Sponsor's protocol ID
PHaLIR
Acronym
PHaLIR
Status last verified
Aug 2025
First submitted
24 Oct 2018
Last updated
19 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Eklov K, Bringman S, Lofgren J, Nygren J, Everhov AH. PHaLIR: prevent hernia after loop ileostomy reversal-a study protocol for a randomized controlled multicenter study. Trials. 2023 Sep 8;24(1):575. doi: 10.1186/s13063-023-07430-w.

    PubMed 37684648

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Mesh reinforcement and No reinforcement in people with Loop Ileostomy, run by Karolinska Institutet at 4 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Åsa Hallqvist Everhov, MD, PhD (+46702264127, asa.hallqvist-everhov@sll.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hernia (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03720262, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in